|
1
|
Allers K, Essue BM, Hackett ML, Muhunthan
J, Anderson CS, Pickles K, Scheibe F and Jan S: The economic impact
of epilepsy: A systematic review. BMC Neurol. 15:2452015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sauro KM, Wiebe S, Dunkley C, Janszky J,
Kumlien E, Moshé S, Nakasato N, Pedley TA, Perucca E, Senties H, et
al: The current state of epilepsy guidelines: A systematic review.
Epilepsia. 57:13–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rathore C and Paterson R: Stopping
antiepileptic drugs in patients with epilepsy in remission: Why,
when and how? Neurol India. 62:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Markoula S, Teotonio R, Ratnaraj N, Duncan
JS, Sander JW and Patsalos PN: Lacosamide serum concentrations in
adult patients with epilepsy: The influence of gender, age, dose,
and concomitant antiepileptic drugs. Ther Drug Monit. 36:494–498.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Braun KP and Schmidt D: Stopping
antiepileptic drugs in seizure-free patients. Curr Opin Neurol.
27:219–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stewart E, Catroppa C and Lah S: Theory of
mind in patients with epilepsy: A systematic review and
meta-analysis. Neuropsychol Rev. 26:3–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Xing DG, Ma EM, Qiu B, Ou SW and
Wang YJ: Microsurgical outcomes of secondary epilepsy from
hippocampal lesions: A report of 56 cases and literature review.
Turk Neurosurg. 26:29–38. 2016.PubMed/NCBI
|
|
8
|
Verrotti A, Matricardi S, Rinaldi VE,
Prezioso G and Coppola G: Neuropsychological impairment in
childhood absence epilepsy: Review of the literature. J Neurol Sci.
359:59–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Buckmaster PS and Haney MM: Factors
affecting outcomes of pilocarpine treatment in a mouse model of
temporal lobe epilepsy. Epilepsy Res. 102:153–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sanabria-Castro A, Henriquez-Varela F,
Lara-Maier S, Monge-Bonilla C and Sittenfeld-Appel M:
Characteristics of patients with refractory epilepsy attended in a
tertiary referral center in Costa Rica. Rev Neurol. 63:58–64.
2016.(In Spanish). PubMed/NCBI
|
|
11
|
Horvath GA, Demos M, Shyr C, Matthews A,
Zhang L, Race S, Stockler-Ipsiroglu S, Van Allen MI, Mancarci O,
Toker L, et al: Secondary neurotransmitter deficiencies in epilepsy
caused by voltage-gated sodium channelopathies: A potential
treatment target? Mol Genet Metab. 117:42–48. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen Y, Liao Y, Feng G, Gu X and Wan S:
Uterine artery embolization for hemorrhage resulting from
second-trimester abortion in women with scarred uterus: Report of
two cases. Int J Clin Exp Med. 8:14196–14202. 2015.PubMed/NCBI
|
|
13
|
Liu J, Liu Z, Ding H and Yang X: Adherence
to treatment and influencing factors in a sample of Chinese
epilepsy patients. Epileptic Disord. 15:289–294. 2013.PubMed/NCBI
|
|
14
|
Möttönen T, Katisko J, Haapasalo J,
Tähtinen T, Saastamoinen A, Peltola J, Öhman J and Lehtimäki K: The
correlation between intraoperative microelectrode recording and
3-Tesla MRI in patients undergoing ANT-DBS for refractory epilepsy.
Stereotact Funct Neurosurg. 94:86–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lambrechts DA, Brandt-Wouters E,
Verschuure P, Vles HS and Majoie MJ: A prospective study on changes
in blood levels of cholecystokinin-8 and leptin in patients with
refractory epilepsy treated with the ketogenic diet. Epilepsy Res.
127:87–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu YX, Wang HQ, Yan J, Sun XB, Guo JC and
Zhu CQ: Antibody binding to cell surface amyloid precursor protein
induces neuronal injury by deregulating the phosphorylation of
focal adhesion signaling related proteins. Neurosci Lett.
465:276–281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bès C, Troadec S, Chentouf M, Breton H,
Lajoix AD, Heitz F, Gross R, Plückthun A and Chardès T: PIN-bodies:
A new class of antibody-like proteins with CD4 specificity derived
from the protein inhibitor of neuronal nitric oxide synthase.
Biochem Biophys Res Commun. 343:334–344. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liimatainen S, Peltola J, Hietaharju A,
Sabater L and Lang B: Lack of antibodies to NMDAR or VGKC-complex
in GAD and cardiolipin antibody-positive refractory epilepsy.
Epilepsy Res. 108:592–596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Watanabe O: Voltage-gated potassium
channel-complex antibodies associated encephalopathy and related
diseases. Brain Nerve. 68:1011–1023. 2016.(In Japanese). PubMed/NCBI
|
|
20
|
Lilleker JB, Jones MS and Mohanraj R: VGKC
complex antibodies in epilepsy: Diagnostic yield and therapeutic
implications. Seizure. 22:776–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Elst LT, Klöppel S and Rauer S:
Voltage-gated potassium channel/LGI1 antibody-associated
encephalopathy may cause brief psychotic disorder. J Clin
Psychiatry. 72:722–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lang B, Makuch M, Moloney T, Dettmann I,
Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, et
al: Intracellular and non-neuronal targets of voltage-gated
potassium channel complex antibodies. J Neurol Neurosurg
Psychiatry. 88:353–361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Somers KJ and Sola CL: Voltage-gated
potassium channel-complex antibody-associated limbic encephalitis.
Psychosomatics. 52:78–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aradillas E and Schwartzman RJ:
Kinesigenic dyskinesia in a case of voltage-gated potassium
channel-complex protein antibody encephalitis. Arch Neurol.
68:529–532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Irani SR, Stagg CJ, Schott JM, Rosenthal
CR, Schneider SA, Pettingill P, Pettingill R, Waters P, Thomas A,
Voets NL, et al: Faciobrachial dystonic seizures: The influence of
immunotherapy on seizure control and prevention of cognitive
impairment in a broadening phenotype. Brain. 136:3151–3162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
González Otárula KA, Ugarnes G, Suárez
Fernández M and D'Giano C: Faciobrachial dystonic seizures.
Semiologic diagnosis in limbic encephalitis. Medicina (B Aires).
75:407–409. 2015.(In Spanish). PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Teoh EJ, McGowan DR, Bradley KM, Belcher
E, Black E, Moore A, Sykes A and Gleeson FV: 18F-FDG PET/CT
assessment of histopathologically confirmed mediastinal lymph nodes
in non-small cell lung cancer using a penalised likelihood
reconstruction. Eur Radiol. 26:4098–4106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bharmal AV, Kent BA, Bussey TJ and Saksida
LM: Performance of transgenic TgTau-P301L mice in a 5-choice serial
reaction time task (5-CSRTT) as a model of Alzheimer's disease.
Psychiatr Danub. 27 Suppl 1:S515–S525. 2015.PubMed/NCBI
|
|
30
|
Vaisburd S, Shemer Z, Yeheskel A, Giladi E
and Gozes I: Risperidone and NAP protect cognition and normalize
gene expression in a schizophrenia mouse model. Sci Rep.
5:163002015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dennis M, Mead G, Doubal F and Graham C:
Determining the modified Rankin score after stroke by postal and
telephone questionnaires. Stroke. 43:851–853. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rossetti AO, Logroscino G, Milligan TA,
Michaelides C, Ruffieux C and Bromfield EB: Status epilepticus
severity score (STESS): A tool to orient early treatment strategy.
J Neurol. 255:1561–1566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Khodaie B, Lotfinia AA, Ahmadi M, Lotfinia
M, Jafarian M, Karimzadeh F, Coulon P and Gorji A: Structural and
functional effects of social isolation on the hippocampus of rats
with traumatic brain injury. Behav Brain Res. 278:55–65. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arida RM, de Almeida AC, Cavalheiro EA and
Scorza FA: Experimental and clinical findings from physical
exercise as complementary therapy for epilepsy. Epilepsy Behav.
26:273–278. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sandow N, Kim S, Raue C, Päsler D, Klaft
ZJ, Antonio LL, Hollnagel JO, Kovacs R, Kann O, Horn P, et al: Drug
resistance in cortical and hippocampal slices from resected tissue
of epilepsy patients: No significant impact of p-glycoprotein and
multidrug resistance-associated proteins. Front Neurol. 6:302015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huda S, Wong SH, Pettingill P, O'Connell
D, Vincent A and Steiger M: An 11-year retrospective experience of
antibodies against the voltage-gated potassium channel (VGKC)
complex from a tertiary neurological centre. J Neurol. 262:418–424.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Radja GK and Cavanna AE: Treatment of VGKC
complex antibody-associated limbic encephalitis: A systematic
review. J Neuropsychiatry Clin Neurosci. 25:264–271. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park SB: The clinical relevance of voltage
gated potassium channel (VGKC)-complex antibodies: The story is
still unfolding. J Neurol Neurosurg Psychiatry. 85:5962014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Watanabe O: Anti-VGKC complex antibody
associated limbic encephalitis. Nihon Rinsho. 73 Suppl 7:S613–S618.
2015.(In Japanese).
|
|
40
|
Menon P, Kiernan MC and Vucic S: Cortical
hyperexcitability precedes lower motor neuron dysfunction in ALS.
Clin Neurophysiol. 126:803–809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nuwer MO, Picchione KE and Bhattacharjee
A: PKA-induced internalization of slack KNa channels produces
dorsal root ganglion neuron hyperexcitability. J Neurosci.
30:14165–14172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sotgiu ML and Biella G: Differential
effects of MK-801, a N-methyl-D-aspartate non-competitive
antagonist, on the dorsal horn neuron hyperactivity and
hyperexcitability in neuropathic rats. Neurosci Lett. 283:153–156.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Murro AM, Park YD, King DW, Gallagher BB,
Smith JR, Yaghmai F, Toro V, Figueroa RE, Loring DW and Littleton
W: Seizure localization in temporal lobe epilepsy: A comparison of
scalp-sphenoidal EEG and volumetric MRI. Neurology. 43:2531–2533.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Englot DJ, Nagarajan SS, Imber BS, Raygor
KP, Honma SM, Mizuiri D, Mantle M, Knowlton RC, Kirsch HE and Chang
EF: Epileptogenic zone localization using magnetoencephalography
predicts seizure freedom in epilepsy surgery. Epilepsia.
56:949–958. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Marson AG, Hutton JL, Leach JP, Castillo
S, Schmidt D, White S, Chaisewikul R, Privitera M and Chadwick DW:
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug
resistant localization-related epilepsy: A systematic review.
Epilepsy Res. 46:259–270. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chaisewikul R, Privitera MD, Hutton JL and
Marson AG: Levetiracetam add-on for drug-resistant localization
related (partial) epilepsy. Cochrane Database Syst Rev: CD001901.
2001. View Article : Google Scholar
|
|
47
|
Dubey D and Porter BE: CRTC1 nuclear
localization in the hippocampus of the pilocarpine-induced status
epilepticus model of temporal lobe epilepsy. Neuroscience.
320:57–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bourque M, Morissette M and Di Paolo T:
Neuroprotection in Parkinsonian-treated mice via estrogen receptor
α activation requires G protein-coupled estrogen receptor 1.
Neuropharmacology. 95:343–352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Loebel A and Citrome L: Lurasidone: A
novel antipsychotic agent for the treatment of schizophrenia and
bipolar depression. BJPsych Bull. 39:237–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Loebel A, Brams M, Goldman RS, Silva R,
Hernandez D, Deng L, Mankoski R and Findling RL: Lurasidone for the
treatment of irritability associated with autistic disorder. J
Autism Dev Disord. 46:1153–1163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Calabrese J, Rajagopalan K, Ng-Mak D,
Bacci ED, Wyrwich K, Pikalov A and Loebel A: Effect of lurasidone
on meaningful change in health-related quality of life in patients
with bipolar depression. Int Clin Psychopharmacol. 31:147–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Enomoto T, Ishibashi T, Tokuda K, Ishiyama
T, Toma S and Ito A: Lurasidone reverses MK-801-induced impairment
of learning and memory in the Morris water maze and radial-arm maze
tests in rats. Behav Brain Res. 186:197–207. 2008. View Article : Google Scholar : PubMed/NCBI
|
